Section Arrow
Quote
ISPC.NASDAQ
- iSpecimen Inc
(Financial Status)
Quotes are at least 15-min delayed:2025/11/08 10:29 EST
Regular Hours
Last
 0.6379
-0.0001 (-0.02%)
Day High 
0.6591 
Prev. Close
0.638 
1-M High
1.06 
Volume 
214.22K 
Bid
0.5803
Ask
0.6298
Day Low
0.55 
Open
0.621 
1-M Low
0.612 
Market Cap 
6.23M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 0.76 
20-SMA 0.78 
50-SMA 1.05 
52-W High 4.9 
52-W Low 0.612 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-8.91/--
Enterprise Value
6.50M
Balance Sheet
Book Value Per Share
0.06
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
9.29M
Operating Revenue Per Share
1.06
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
SHCSotera Health Company15.68-0.33-2.06%77.15PE
NEOGNeogen Corp6.4+0.42+7.02%879PE
OPKOPKO Health1.34-0.04-2.90%-- 
DHRDanaher Corp209.94-0.73-0.35%43.47PE
EXASExact Sciences Corp66.18-1.04-1.55%-- 
Quotes are at least 15-min delayed：2025/11/08 10:29 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.